Atrial fibrillation

it reassessed. Numerator – the number in the denominator who have their anticoagulation reassessed. Denominator – the number of adults with poor anticoagulation control. Data source: Local data collection. Outcome a) Rates of thromboembolic complications. Data source: Local data collection. b) Patient experience. Data source: Local data collection. What the quality statement means for different audiences Service providers (secondary care services) have systems in place with written clinical protocols for reassessing anticoagulation in adults with atrial fibrillation who are taking a vitamin K antagonist and have poor anticoagulation control. Healthcare professionals reassess anticoagulation and record the results for adults with atrial fibrillation who are taking a vitamin K antagonist and have poor anticoagulation control. Commissioners commission secondary care services that have written clinical protocols for reassessing anticoagulation in adults with atrial fibrillation who are taking a vitamin K antagonist and have poor anticoagulation control. Adults with atrial fibrillation who are taking a type of anticoagulant called a vitamin K antagonist (such as warfarin) have their anticoagulation treatment reassessed if regular tests show that it isn't working well. Source guidance Atrial fibrillation: diagnosis and management. NICE guideline 196 (2021), recommendations 1.6.10 to 1.6.13 and 1.6.17 Definitions of terms used in this
